Investor
FT Global Pharmaceutical and Biotech Summit
A senior executive forum discussing the geopolitical, regulatory, and commercial dynamics of the pharmaceutical industry.
- When
- November, Early November
- Where
- London, United KingdomView on Google Maps
- Format
- Hybrid
- Organiser
- Financial Times
- Region
- Europe
- Scale
- About 400 attendees
- Founded
- 2013
The Signal
The FT Global Pharmaceutical and Biotech Summit is a high level business event organized by the Financial Times. It convenes global pharmaceutical chief executives, biotechnology founders, and life sciences investors. Discussions focus on drug pricing policies, geopolitical supply chain issues, and therapeutic pipelines. For life science investors and advanced digital health operators, it provides a macroeconomic view of pharmaceutical sector priorities and investment trends.
What to expect
- Debates on drug pricing legislation
- Analyses of pharmaceutical merger and acquisition activity
- Discussions on the commercialization of cell and gene therapies
Who is in the room
Pharmaceutical chief executives, biotechnology founders, life science venture capitalists, and policy experts.
Background
Established by the Financial Times, the summit has served as a critical platform for corporate strategy and policy debates. It has increasingly incorporated digital transformation and artificial intelligence integration into its core agenda.
Related events
Running this event, or spotted something out of date?